Patents by Inventor Carol L. O'Brian

Carol L. O'Brian has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Curable epoxy resin systems containing mixtures of amine hardeners and an excess of epoxide groups
    Patent number: 9688808
    Abstract: Fiber reinforced epoxy resin composites are produced using a specific epoxy resin system. The epoxy resin system contains at least one polyglycidyl ether of a polyphenol. The system also contains a hardener that contains a mixture of aminocyclohexanealkylamine and polyalkylene polyamine hardeners. The ratio of epoxy resin groups to amine hydrogen groups is from 1.05 to 1.50. The epoxy resin system contains a tertiary amine catalyst such as a tertiaryaminophenol, a benzyl tertiary amine or an imidazole compound.
    Type: Grant
    Filed: June 21, 2012
    Date of Patent: June 27, 2017
    Assignee: Dow Global Technologies LLC
    Inventors: Timothy A. Morley, Radhakrishnan Karunakaran, Carol L. O'Connell, Nigel Shields, Nikhil K. Verghese, Martin Reimers
  • CURABLE EPOXY RESIN SYSTEMS CONTAINING MIXTURES OF AMINE HARDENERS AND AN EXCESS OF EPOXIDE GROUPS
    Publication number: 20130005853
    Abstract: Fiber reinforced epoxy resin composites are produced using a specific epoxy resin system. The epoxy resin system contains at least one polyglycidyl ether of a polyphenol. The system also contains a hardener that contains a mixture of aminocyclohexanealkylamine and polyalkylene polyamine hardeners. The ratio of epoxy resin groups to amine hydrogen groups is from 1.05 to 1.50. The epoxy resin system contains a tertiary amine catalyst such as a tertiaryaminophenol, a benzyl tertiary amine or an imidazole compound.
    Type: Application
    Filed: June 21, 2012
    Publication date: January 3, 2013
    Inventors: Timothy A. Morley, Radhakrishnan Karunakaran, Carol L. O'Connell, Nigel Shields, Nikhil K. Verghese, Martin Reimers
  • Modulators of RabGGT and methods of use thereof
    Publication number: 20040142888
    Abstract: The present invention provides methods for inducing apoptosis in a cell, the methods generally involving contacting the cell with an agent that reduces the level and/or activity of RabGGT. The present invention further provides methods for treating a disorder related to unwanted cell proliferation in an individual, the methods generally involving administering to the individual an agent that reduces the level and/or activity of RabGGT. The present invention further provides methods for reducing apoptosis in a cell, the methods generally involving increasing the level and/or activity of RabGGT in the cell. The present invention further provides methods for treating disorders associated with excessive apoptosis. The present invention further provides methods for identifying a cell that is amenable to treatment with the methods of the present invention. The present invention further provides methods for modulating a binding event between RabGGT and a RabGGT interacting protein.
    Type: Application
    Filed: August 7, 2003
    Publication date: July 22, 2004
    Inventors: Veeraswamy Manne, Mark Lynch, Petra B. Ross-MacDonald, Terry Stouch, Naomi Laing, Pamela Carroll, Kevin Fitzgerald, Louis J. Lombardo, Michael R. Costa, Mark E. Maxwell, Rachel M. Kindt, Mark R. Lackner, Tak Hung, Carol L. O'Brian, Hai Guang Zhang, Katherine S. Brown, Jae Moon Lee
  • Modulating insulin receptor signaling through targeting FACL
    Publication number: 20030138832
    Abstract: Human FACL genes are identified as modulators of INR signaling and thus are therapeutic targets for disorders associated with defective INR signaling. Methods for identifying modulators of FACL, comprising screening for agents that modulate the activity of FACL are provided.
    Type: Application
    Filed: December 18, 2002
    Publication date: July 24, 2003
    Inventors: Lisa C. Kadyk, Carol L. O'Brien